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Summary
INTRODUCTION: The 30-day post-discharge readmis-
sion rate is a quality indicator that may reflect suboptimal
care. The computerised algorithm SQLape® can retro-
spectively identify a potentially avoidable readmission
(PARA) with high sensitivity and specificity. We retrospec-
tively analysed the hospital stays of patients readmitted to
the Department of Internal Medicine of the CHUV (Centre
Hospitalier Universitaire Vaudois) in order to quantify the
proportion of PARAs and derive a risk prediction model.
METHOD: All hospitalisations between January 2009 and
December 2011 in our division of general internal medi-
cine were analysed. Readmissions within 30 days of dis-
charge were categorised using SQLape®. The impact on
PARAs was tested for various clinical and nonclinical fac-
tors. The performance of the developed model was com-
pared with the well-validated LACE and HOSPITAL
scores.
RESULTS: From a total of 11 074 hospital stays, 777 (7%)
were followed with PARA within 30 days. By analysing a
group of 6729 eligible stays, defined in particular by the
patients' returning to their place of residence (home or res-
idential care centre), we identified the following risk fac-
tors: ≥1 hospitalisation in the year preceding index admis-
sion, Charlson score >1, active cancer, hyponatraemia,
length of stay >11 days, prescription of ≥15 different med-
ications during the stay. These variables were used to de-
rive a risk prediction model for PARA with a good discrim-
inatory power (C-statistic 0.70) and calibration (p = 0.69).
Patients were then classified as low (16.4%), intermediate
(49.4%) or high (34.2%) risk of PARA. The estimated risk
of PARA for each category was 3.5%, 8.7% and 19.6%,
respectively. The LACE and the HOSPITAL scores were
significantly correlated with the PARA risk. The discrimina-
tory power of the LACE (C-statistic 0.61) and the HOSPI-
TAL (C-statistic 0.54) were lower than our model.
CONCLUSION: Our model identifies patients at high risk
of 30-day PARA with a good performance. It could be used
to target transition of care interventions. Nevertheless, this
model should be validated on more data and could be im-
proved with additional parameters. Our results highlight
the difficulty to generalise one model in the context of dif-
ferent healthcare systems.
Key words: patient readmission, risk factors, prediction
model, transition of care, quality of care, preventive man-
agement strategies
Introduction
Identifying patients at high risk of post-discharge readmis-
sion is a crucial step in lowering readmission rates. How-
ever, there is a need to distinguish between an unavoid-
able readmission and a potentially avoidable readmission
(PARA). PARA is defined as unforeseen readmission relat-
ed to a condition already known during the index hospital-
isation. The PARA rate is the main indicator of a success-
ful transition between hospital and home. These particular
readmissions represent the improvement margin for imple-
menting specific interventions that may reduce readmis-
sion rates.
A computerised validated algorithm, SQLape® (Striving
for Quality Level and analysing of patient expenditures)
was developed to identify PARAs. It is calculated from
Swiss medical statistics, in particular International Clas-
sification of Diseases (ICD) and Swiss Procedure codes
(abridged CHOP). It retrospectively identified PARAs with
high sensitivity (96%) and specificity (96%) when com-
pared with medical record review in a random sample
of admission-readmission pair [1, 2]. However, since first
publication, the Swiss classification has been adapted, and
specificity and/or sensitivity have not been evaluated in
other studies. This indicator is also employed on a wider
scale in Switzerland by the Swiss Association for Quality
in Hospitals and Clinics in order to better evaluate quality
of care.
Several risk factors for unplanned readmission within 30
days of hospital discharge have been identified in various
studies [3–7]. This has led to the development of risk pre-
diction models for readmission. Their goal is to help clini-
cians to identify patients at high risk of readmission so that
preventive strategies may be put in place. However, these
models have often been validated in very different settings
(surgical vs medical wards, hospitals of different sizes,
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and different countries with specific healthcare systems).
Moreover, many models have investigated all readmissions
together rather than PARAs. These various models have
ultimately proved to only moderately predict readmission,
as demonstrated by two publications, including a system-
atic review [8, 9] in which only one of 36 models investi-
gated PARA [2]. Several models used the Charlson index,
which was developed over 20 years ago and specifically
designed to predict mortality. In view of the complexity of
current care, this index alone does not suffice to predict
PARAs. More recently, the HOSPITAL score has been de-
veloped and validated in Boston [7]. This score predicts
PARAs, but, since health systems differ, a single score is
not enough to predict PARAs. The LACE score predicts
the risk of early death or unplanned readmission. The per-
formance of the LACE seems to be poor in older people
and in any case lower than the HOSPITAL score [10, 11].
The LACE and the HOSPITAL scores were externally val-
idated. The HOSPITAL score was validated externally in
a large cohort of 117 065 patients in four countries, in-
cluding Bern for Switzerland [12]. An adapted HOSPITAL
score was validated with 346 patients >50 years old in Fri-
bourg, Switzerland [13]. Thus, a wider application of the
original HOSPITAL score in Switzerland may be limited:
(1) the mean length of hospital stay is longer in Switzer-
land than in the USA; (2) a specific oncology division is
not available in all hospitals; (3) most admissions in a ser-
vice of internal medicine are urgent and not elective.
Our study had two aims, of which the first was to retro-
spectively calculate the proportion of PARAs at day 30
following discharge for all hospitalisations in the Depart-
ment of Internal Medicine of the Centre Hospitalier Uni-
versitaire Vaudois (CHUV) in Lausanne, Switzerland. Our
teaching hospital department contains 187 acute care beds,
including 14 intermediate care beds. It is the only internal
medicine department for around 300 000 patients. Second-
ly, we sought to develop a model to predict PARAs for the
patients returning back home, identifying factors able to
discriminate between the groups “hospitalisation followed
by PARA” and “hospitalisation not followed by readmis-
sion”. The performance of this model was then compared
with the LACE and the HOSPITAL scores.
Methods
From the 11 074 hospitalisations between 1 January 2009,
and 31 December 2011, we included those whose destina-
tion after discharge was their place of residence, i.e., their
home or a residential care centre. Hospitalisations that end-
ed in a transfer to another department, another hospital, in-
tensive care, or a rehabilitation centre were excluded, this
being considered as treatment continuation and not dis-
charge. The aim was to build a risk prediction model for
PARA of a population for whom improvement measures
could be put in place. Thus, we excluded from the analysis
hospitalisations that were interrupted by death, hospitalisa-
tions followed by a readmission that was ineligible for the
algorithm and hospitalisations followed by an unavoidable
readmission according to SQLape®. The question that we
needed to answer was therefore: in the population of pa-
tients who leave our department to return to their place of
residence, what differentiates those who will be readmit-
ted for potentially avoidable reasons from those who will
not be readmitted? This question enabled us to define the
inclusion and exclusion criteria for all the hospitalisations
(fig. 1).
Data extraction
Data relating to the hospitalisations was extracted from the
hospital data system. It was drawn from three categories:
medical-administrative data, laboratory results and infor-
mation on pharmacological treatments.
Medical-administrative data (data warehouse)
With these data, we were able to identify hospitalisation
durations, diagnoses and procedures. The readmissions
and times to readmission were calculated from the data-
base using patient numbers, as well as the dates of both
admission and discharge. Only patients readmitted to the
CHUV could be identified as readmitted. Data extracted
were: age, gender, where the patient came from on admis-
sion, where the patient went to at discharge, diagnosis-re-
lated group and severity, Charlson score [14] as calculated
according to diagnosis codes (ICD-10), Swiss procedure
codes (CHOP), duration of index admission, and number
of admissions to the CHUV at 6 and 12 months before-
hand. When a patient was hospitalised several times, each
readmission became the index stay for the following read-
mission.
PARAs were identified by means of the computer program
SQLape® (version 2011). All patients were considered eli-
gible, except those who died or were transferred to another
hospital, those who were outpatient surgery candidates and
those living abroad. Readmission (of eligible patients only)
was deemed potentially avoidable if it was related to a di-
agnosis already known during the index stay, was not fore-
seeable during the index stay, and occurred within 30 days
of discharge after the index stay. The following readmis-
sions were considered to be planned and, therefore, un-
avoidable: organ transplantation, chemotherapy or radio-
therapy, specific surgical procedures or childbirth. Read-
missions owing to new conditions that were not known
during the index day were deemed unavoidable.
The hospital stays studied were divided into five groups
(see fig. 2 in the Results section): (1) interrupted by death;
(2) not followed by readmission within 30 days; and (3)
Figure 1: Details of hospitalisations included in and excluded from
the analysis to develop a risk prediction model for potentially
avoidable readmission (PARA).
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followed by readmission within 30 days. This last group
was subdivided into: (3a) ineligible according to SQLape®
(mostly transferred patients); (3b) unavoidable according
to SQLape® (planned readmission or related to a new diag-
nosis); and (3c) PARA according to SQLape®.
Laboratory analysis results during index stay
We retained the last value available during the index stay
to correlate with the state of the patient at discharge, at the
beginning of the transition of care period. We chose pa-
rameters identified in the literature as being of prognos-
tic value for morbidity and mortality, such as anaemia [3,
7] or low blood sodium levels [15]. Taking the literature
into account, and for simplicity's sake, we opted for a di-
chotomous distinction of “risk value” versus “non-risk or
unavailable value”. We defined risk laboratory values as:
blood sodium <135 mmol/l; blood haemoglobin male <133
g/l or female <117 g/l; blood creatinine: male >106 μmol/l
or female >80 μmol/l; blood urea male >7.7 mmol/l or fe-
male >6.4 mmol/l; blood albumin <35 g/l; serum alanine
aminotransferase male >60 U/l or female >36 U/l.
Drugs prescribed during index stay and at discharge
From among the 5000 medications available in the hospi-
tal, we defined the following categories: oral or parenter-
al anticoagulants, oral or parenteral antidiabetics, nons-
teroidal anti-inflammatory drugs and antiaggregants, sys-
temic steroids, diuretics, opioids, benzodiazepines, antide-
pressants, neuroleptics, and, lastly, all the others. We based
our selection of these different categories on literature re-
garding early readmissions in general and emergency ad-
missions owing to drug-related adverse events [9, 16–25].
The following data were extracted: number of medications
prescribed during the stay, number of different prescribers
during the stay and number of medications prescribed at
discharge. For these data, all the medications available in
the hospital were considered.
LACE and HOSPITAL scores
We compared the performance of our score with the LACE
and HOSPITAL scores. We collected the information on
the four variables included in the LACE score and the sev-
en variables included in the HOSPITAL score, using the
same definitions as the derivation studies [3, 7]. We cal-
culated then the C-statistic for both scores in our cohort.
The LACE score is the acronym for four variables: Length
of stay, Acuity of the admission; Comorbidity (Charlson
comorbidity index score) and Emergency department use
(number of visits in the 6 months before admission). The
scoring system ranges from 0 to a maximum of 19 points.
The HOSPITAL score is the acronym for seven variables:
Haemoglobin at discharge (<120g/l), Oncology service,
Sodium at discharge (<135 mmol/l), Procedures per-
formed, Index admission Type (emergency), number of
Admissions in the previous year and Length of stay (>5
days). The scoring system ranges from 0 to a maximum
of 13 points. The risk for PARA is classified as low (0–4
points), intermediate (5–6 points) or high (>7 points). In
our cohort, 79.9%, 18.8% and 1.3%, respectively, of the
patients were classified as low, intermediate or high risk of
PARA.
Statistical analysis
Among all variables described in the previous sections,
bivariate analysis was used to select the factors that dis-
criminate between stays followed by a PARA and those
that were not followed by any readmission within 30 days
in the included population. The nonparametric two-tailed
Wilcoxon test was used for all continuous variables, as
some of the variables were highly non-normal. The chi-
square test was used for categorical variables. The thresh-
old for significance was 0.05 for all tests. A multivariate
regression was then applied with stepwise inclusion of the
retained factors, and age and gender as these variables
might have an impact on the outcome when associated
with other frailty scores. On bivariate analysis, the follow-
ing factors were highly associated with PARA: length of
stay (mean ± standard deviation, p <0.001), length of stay
>11 days (p <0.001), cancer diagnosis (oncological diag-
nosis on admission or during hospitalisation, p <0.001),
cancer diagnosis with metastasis (p <0.001), ≥1 admission
in the previous 12 months (p <0.001), ≥15 different med-
ications prescribed during the stay (p <0.001), Charlson
score >1 (p <0.001), blood sodium <135 mmol/l (p
<0.001), female sex (p = 0.007). The stepwise threshold
level for addition of the model was 0.1, and for removal
from the model was 0.2. The following variables were re-
tained in the stepwise procedure: at least one hospitali-
sation in the 12 months preceding the index admission,
cancer diagnosis with metastasis, cancer diagnosis without
metastasis and without antidepressant, blood sodium <135
mmol/l, Charlson score >1, length of stay >11 days, and
the prescription of at least 15 different medications during
the stay. Adjusted odds ratios were calculated. A score was
then created to define three levels of risk for PARA: low
(≈5%), intermediate (≈10%), and high (≈20%). The result-
ing model was then tested for validity (assumptions), sen-
sitivity, and specificity. The discrimination power of the
score was tested with the C-statistic (or area under receiv-
er operating characteristic [ROC] curve). The calibration
of the score was tested using the Hosmer-Lemeshow good-
ness-of-fit test. Stata® Statistical Software Release 13 was
used for all statistical analysis (StataCorp. 2013. College
Station, TX: StataCorp LP).
Results
Overall, 11 074 hospitalisations were recorded in the
CHUV Department of Internal Medicine between 1 Jan-
uary 2009, and 31 December, 2011. In total, 777 stays
(7.02%) were followed by a PARA according to SQLape®.
After exclusion of stays interrupted by death (n = 927;
8.37%), transfers to places other than the place of resi-
dence (n = 2973; 26.85%), and unavoidable or ineligible
readmissions according to SQLape® (n = 445; 4.02%), we
retained an analysis group of 6729 hospital stays that were
followed by a return to the place of residence. Of these,
777 stays were followed by a PARA; 5952 patients were
not readmitted (fig. 2).
The main characteristics distinguishing patients of all hos-
pital stays (n = 11 074) from those included in the analysis
(n = 6729) have been provided in Table 1. Table 2 shows
the main distinctions between stays followed by a PARA
and those not followed by readmission among eligible
stays, on bivariate analysis, (n = 6729).
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On multivariate analysis, the variables significantly predic-
tive of readmission were: at least one hospitalisation in the
12 months preceding the index admission, cancer diagno-
sis, blood sodium <135 mmol/, Charlson score >1, length
of stay >11 days, and the prescription of at least 15 differ-
ent medications during the stay (table 3). The prescription
of an antidepressant or neuroleptic during the stay had a
protective effect in cancer patients. We observed that the
“female” variable was no longer significantly discrimina-
Figure 2: Situation at 30 days after discharge for all hospital stays
in the CHUV Department of Internal Medicine (n = 11 074).PARA =
potentially avoidable readmission
tive on multivariate analysis. A score was then created. It
ranged from 0 to 10.5 according to the points given at each
variable. Three risk categories of PARA were determined:
low (0–1.5 points), intermediate (1.5–5 points), high (>5
points).
The model thus developed has good predictive value for
the risk of PARA, with an area under the ROC curve
of 0.696 (fig. 3). The p-value of the Hosmer-Lemeshow
goodness-of-fit statistic was 0.69, indicating a good cali-
bration. The patients were then classified as low (n = 1106,
16.4%), intermediate (n = 3322, 49.4%) or high (n = 2301,
34.2%) risk of PARA. The estimated risk of PARA for each
category was 3.5%, 8.7% and 19.6%, respectively. The C-
statistic for the level of risk was good, but slightly lower
at 0.65. The LACE and the HOSPITAL scores were both
significantly correlated with the risk of PARA. The dis-
criminatory power of the LACE was lower than our mod-
el, with a C-statistic of 0.61. The discriminatory power of
the HOSPITAL score to predict PARA was lower than the
LACE score and our model, with a C-statistic of 0.54. The
C-statistic increased at 0.59 when the HOSPITAL score
was used as a continuous variable.
Table 1: Patient characteristics of stays included in the analysis (n = 6729) compared with total stays (n = 11 074).
Patient characteristics All stays
(n = 11 074)
Stays included
(n = 6729)
Age (mean ± SD) 72.0 ± 16.8 69.4 ± 17.7
Women (%) 50.3% 49.6%
Came from place of residence (%) 92.7% 96.0%
≥1 admission in the previous 12 months (%) 49.7% 46.9%
Cancer diagnosis without metastasis (%) 20.9% 16.7%
Cancer diagnosis with metastasis (%) 11.1% 7.3%
Length of stay, mean ± SD (median) 15.9 ± 14.7 (11) 13.9 ± 12.1 (12)
SD = standard deviation
Table 2: Patient characteristics that distinguish stays followed by a PARA (n = 777) from those not followed by readmission (n = 5952) among eligible hospital stays (n = 6729).
Variables Not readmitted 30 days after discharge
(n = 5952)
PARA
(n = 777)
p-value
Age (mean ± SD) 69.4 ± 17.8 69.0 ± 16.9 0.148
Length of stay, mean ± SD (median) 13.6 ± 12.0 (11) 16.0 ± 12.7 (12) <0.001
Length of stay >11 days (%) 47.0% 57.1% <0.001
Women (%) 50.2% 45.0% 0.007
Cancer diagnosis 14.3% 34.7% <0.001
Cancer diagnosis with metastasis (%) 5.7% 19.2% <0.001
≥1 admission in the previous 12 months (%) 44.5% 64.7% <0.001
≥15 different medications prescribed during the stay 45.3% 56. 9% <0.001
Charlson score >1 45.9% 67.2% <0.001
Blood sodium <135 mmol/l 4.7% 11.3% <0.001
SD = standard deviation
Table 3: Variables from the multivariate model predicting PARA 30 days after discharge in the included population.
Variable Adj OR Z p-value 95% CI Points
≥1 admission in the previous 12 months (%) 1.96 8.10 <0.001 1.67–2.31 2
Charlson score >1 1.46 3.93 <0.001 1.21–1.76 1.5
Blood sodium <135 mmol/l 2.15 5.63 <0.001 1.65–2.80 2
Length of stay >11 days (%) 1.36 3.66 <0.001 1.15–1.61 1.5
≥15 different medications prescribed during the stay 1.27 2.63 0.009 1.06–1.52 1.5
Cancer diagnosis; interaction with antidepressant therapy:
Cancer diagnosis without metastasis, with antidepressant 1.25 0.94 0.345 0.79–2.00
Cancer diagnosis without metastasis, without antidepressant 1.81 4.38 <0.001 1.39–2.36 2
Cancer diagnosis with metastasis 3.14 9.22 <0.001 2.46–4.00 3
Adj = adjusted; CI = confidence interval; OR = odds ratio; PARA = potentially avoidable readmission
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Discussion
Our study aimed to retrospectively analyse hospital stays
of patients readmitted to the CHUV Department of Internal
Medicine, in order to quantify the proportion of PARAs
and then derive from it a risk prediction model. Of the
11 074 hospital stays analysed, 777 stays (7%) were fol-
lowed by a PARA within 30 days of discharge according to
the SQLape® algorithm. Analysis of our group of hospital-
isations of interest (n = 6729) enabled us to identify the fol-
lowing risk factors: at least one hospitalisation during the
year preceding the index admission, a Charlson score >1,
cancer diagnosis, hyponatraemia, a hospital stay >11 days
or the prescription of at least 15 different medications dur-
ing the stay. These variables were used to derive a good
quality predictive model for PARA (area under the ROC
curve 0.70).
Risk factors
Hospitalisation or emergency department attendance dur-
ing the months preceding the index admission is a risk fac-
tor for readmission that is widely found in the literature [3,
7]. It indicates the patient’s fragility. The Charlson comor-
bidity score has also been highlighted in certain models, as
has the LACE score [3]. It conveys the fact that an accu-
mulation of comorbidities increases the risk of death and
also unplanned readmission. The presence of cancer diag-
nosis was clearly more prevalent in the group of patients
readmitted for potentially avoidable reasons than in those
who were not readmitted, as in other studies [7]. It may
seem surprising that antidepressants had an apparently pro-
tective effect against PARAs in cancer patients. This class
of drugs is often described as being associated with a high
risk of adverse events [17, 25]. Nevertheless, a protective
effect with antidepressants has at times been noted in oth-
er studies [26]. Of note is that the presence of cancer is al-
so taken into account in the Charlson comorbidity score;
this information may thus be partly superfluous. We never-
theless detected no multicollinearity problems in our mod-
el. Low blood sodium levels doubled the risk of PARA in
our study. This confirms the observations in other scores,
like LACE [3] or HOSPITAL [7]. This biological charac-
Figure 3: Area under the receiver operating characteristic (ROC)
curve of the risk prediction model for potentially avoidable read-
mission.
teristic is often the manifestation of a poorly compensated
comorbidity (e.g., cirrhosis or heart failure), a drug-related
adverse effect (thiazide diuretic or aldosterone antagonist),
or inappropriate antidiuretic hormone secretion syndrome
(e.g., due to medication, infection or neoplasia). Median
length of stay was slightly longer in patients readmitted
for potentially avoidable reasons compared with those not
readmitted. This seems logical, since the sickest patients
(according to the Charlson score) exhibit a higher risk of
being readmitted, and since they are also hospitalised for
longer [27]. A longer index stay also increased the risk of
readmission in the LACE [3] and HOSPITAL [7] scores,
since it expresses the greater complexity and fragility of
these patients from medical and social perspectives. Noso-
comial illness, deconditioning and undernourishment in
the hospital may well contribute to lengthening the dura-
tion of the stay. The “prescription of at least 15 different
medications during the stay” variable remained associat-
ed with readmission after multivariate analysis, which un-
doubtedly reflected the complexity of the case. To the best
of our knowledge, this is to date the only model predictive
of readmission that takes this variable into account.
Risk prediction models
Our model had good ability (C-statistic 0.70) and calibra-
tion (Hosmer-Lemeshow 0.69) for predicting the 30-day
risk of PARA. The performance was slightly lower with a
C-statistic at 0.65 for the level of risk. Our model was com-
pared with the LACE and HOSPITAL scores. The C-sta-
tistic was 0.61 for the LACE score and 0.54 for the HOS-
PITAL score. The C-statistic increased, at 0.59, when the
HOSPITAL score was used as a continuous variable.
The HOSPITAL score was externally validated in an inter-
national multicentre study of 117 065 patients discharged
from the medical departments of nine hospitals in four
countries [12]. The discriminatory power of the HOSPI-
TAL score to predict PARA was good, with a C-statistic at
0.72. The C-statistic ranged from 0.78 in Canada to 0.68
in Israel and Switzerland (Bern, University Hospital). The
performance of the HOSPITAL score was lower in our co-
hort since three of seven variables are not discriminative:
oncology service, index admission type and length of stay
(>5 days). These three variables were modified by Aubert
et al. to create an adaptation of the HOSPITAL score [13].
This “new” score showed a good discriminatory power (C-
statistic 0.70) and calibration (Hosmer-Lemeshow 0.77) to
predict the 30-day risk of PARA or death in the depart-
ment of general internal medicine of the Fribourg Canton-
al Hospital. Owing to the differences within the health-
care system in the same country, three different models are
needed in Bern, Fribourg and Lausanne to obtain a good
discriminatory power (C-statistic ≈0.70) to predict PARA.
In the large external validation cohort, the risk of PARA
for the patients with a HOSPITAL score in the low, in-
termediate and high risk groups were 5.8%, 11.9% and
22.8%, respectively [12]. In the Fribourg study, the esti-
mated risks of PARA or death for each category (calculated
with an adapted HOSPITAL score) were 8.2%, 11.3% and
21.6%, respectively [13]. In our cohort, the estimated risk
of PARA for each category was 3.5%, 8.7% and 19.6%, re-
spectively. All these results are very close to the categories
created in the derivation study of the HOSPITAL score [7],
corresponding to 5%, 10% and 20% risk of PARA.
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The C-statistic of the LACE score to predict the 30 days
risk of PARA or death was 0.56 in Fribourg, very close to
the 0.61 described in our cohort [13]. However, the com-
parison with the LACE score has some limitations: (1) it
was derived from a large population of medical and surgi-
cal patients; (2) it quantifies the 30-day risk of unplanned
readmission or death; and (3) its performance seems to be
poor in older people [3, 10].
Limitations and perspectives
Except for the number of admissions before the index hos-
pitalisation, all the variables of our model could change
during hospitalisation. We decided to take into account the
last data available before discharge, because we sought to
highlight “the state of the patient” when he or she left the
hospital. This impedes, however, early identification of pa-
tients at risk of readmission and delays the implementation
of means to reduce this risk. Patient computer files should
provide a risk prediction score for readmission that evolves
during the stay. Certain variables might remain stable (for
instance the number of different medications prescribed),
while others could only worsen (length of stay). We might
also observe an improvement in other variables (e.g., blood
sodium levels and Charlson score). Our model could thus
be used as a dynamic measure, during the stay, of the risk
of PARA. This may render it possible to plan preventive
steps, which often take time to initiate. Nevertheless, the
retrospective design of our study limits the prospective use
of our model. The inclusion of the Charlson score limits
the dynamic aspect of the measure and adds complexity for
real-life use as it refers to 18 clinical diagnoses. Automated
calculation of the score would require all ICD codes, on-
ly available after discharge, and manual calculation of the
Charlson score could be judged too complicated. Contrari-
wise, the HOSPITAL score can be easily calculated before
discharge, and the interventions to prevent readmission can
be started in the hospital.
Our model performed fairly well in predicting PARAs (C-
statistic 0.70), although it still needs to be validated. The
definition of PARAs has some limitations: (1) PARAs were
identified with the validated algorithm, SQLape® and not
with an adjudication made by medical chart review; and
(2) the algorithm SQLape® is regularly adapted. Its sensi-
tivity/specificity, as well as the accuracy of the developed
model, may change. That said, the limited predictive abil-
ity of our model, like other existing models, illustrates the
difficulty in developing models that possess high predic-
tive power, thereby restricting their use in clinical practice.
It is conceivable that use of clinical data, such as patient
functional scores and intensity of nursing care, may fine-
tune prediction [28–32]. The development of computerised
medical files containing prospectively recorded medical
and nursing data should render it possible to improve ex-
isting models.
Now that 30-day post-discharge unplanned readmission
rates are being used as quality and benchmarking indica-
tors between hospitals, it should be remembered that cau-
tion is required when interpreting these rates. For this rea-
son, the absolute value appears of little importance; it is
the “expected” versus “observed” ratio that is determi-
nant. Precisely estimating these rates is still so complex
that even this ratio proves controversial [28]. A systemat-
ic review followed by a meta-analysis by van Walraven et
al. [33, 34] underlined the high variability in readmission
rates deemed to be avoidable. On average, around a quarter
of readmissions were deemed to be avoidable, with rates
varying greatly between the different studies (from 9.9% to
59%). These rates differed depending on the number of ex-
aminers or type of hospital (teaching hospital versus non-
teaching hospital). Studies in which avoidability was based
on administrative data recorded mean rates of 59%, as op-
posed to only 12% in those in which clinical data was used.
Beside the retrospective design leading to possible missing
data in the patients’ records, our study displayed several
other limitations. First, our model has not been validated in
another dataset. Internal validation will be indispensable if
we wish to develop a tailored predictive model for our de-
partment, as will external validation prior to generalising
the model. Secondly, the SQLape® algorithm that we em-
ployed for distinguishing PARAs uses strict definitions
and may over- or even underestimate some readmissions.
For example, the admission of a patient for a femoral
neck fracture following hospitalisation for pneumonia was
deemed to be unavoidable, even if a soporific had been ini-
tiated during the index hospitalisation. It must, however,
be stressed that SQLape® has several advantages: it detects
PARAs with high specificity and sensitivity. It is an al-
gorithm that has been validated with use of Swiss data.
Lastly, since it is a computerised tool, it has the advantage
of avoiding individual sorting, which is subjective and te-
dious. Thirdly, we have no data on patients readmitted to
other hospitals than the CHUV. The consequence of this
may be an underestimation of the readmission rate. Never-
theless, readmissions to other hospitals are rare in our re-
gion since the CHUV is the only public acute care hospital
for Lausanne and its region. Furthermore, the readmission
rate given by the Swiss Association for Quality in Hospi-
tals and Clinics for the CHUV internal medicine depart-
ment is one of the highest in Switzerland. Fourthly, deaths
that occurred outside the CHUV are not known. Several
deaths are thus “hidden” within the category of hospital
stays of non-readmitted patients, which may overestimate
success rates in terms of non-readmission.
As the PARA rate represents an improvement margin for
which implementation of specific interventions may be ef-
fective, risk prediction scores for readmission are only a
part of the process. Therefore continued efforts are need-
ed to identify the patients most at risk of PARA. There
are factors that cannot be influenced, whereas others can
be improved, for example through medication reconcilia-
tion, the creation of a personalised discharge plan, or the
participation of a nurse for health coaching and follow-
up [35–37]. Other improvement avenues may also involve
better communication with the doctors and caregivers tak-
ing over outside the hospital.
Conclusion
Our model identifies patients at high risk of 30-day po-
tentially avoidable readmission with a fairly good perfor-
mance. It could be used to target transition of care inter-
ventions. Nevertheless, this model should be validated on
more data and could be improved with additional parame-
ters. Even though our study confirms some recurrent risk
factors of readmission found in other studies (previous ad-
mission, longer length of stay, presence of cancer, anaemia
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and hyponatraemia) other variables, more “locally tai-
lored”, are probably necessary to improve accuracy of fu-
ture models. A higher number of medications prescribed
during the stay is an original parameter we found in our
model, to point out complexity of the case, associated with
an increased risk of preventable readmission.
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